VAP Intervention Information

Slides:



Advertisements
Similar presentations
The Eradication of VAP in Scotland Martin Hughes Nov 2010.
Advertisements

Prevention of Ventilator Associated Pneumonia
PREVENTION OF CATHETER ASSOCIATED URINARY TRACT INFECTIONS (CAUTIs)
Eliminate Ventilator-Associated Pneumonia. What Is a Ventilator? A machine that supports breathing for those that have lost the ability to breathe Short.
Beyond VAP: Identifying areas for improvement to prevent ventilator-associated conditions Michael Klompas MD, MPH, FRCPC, FIDSA Harvard Medical School,
Reducing Ventilator Associated Pneumonia in Adults Intensive Care Units Confidential: Quality Improvement Material.
Sahar Elkaradawy Assistant Professor in Anaesthesia and Intensive Care Unite.
How We Zapped VAP During the past six years, our Multidisciplinary Pneumonia Team has worked to reduce Ventilator Associated Pneumonia (VAP). Through these.
OUR LADY OF LOURDES MEMORIAL HOSPITAL Binghamton, New York Reducing Complications From Ventilators in ICU: Ventilator Associated Pneumonia (VAP)
©Copyright 2010 IHI/R. Lloyd Measurement Plan Worksheet VAP Measure NameType (Process, Outcome or Balancing) Driver addressed by this measure Operational.
Linda R Greene Rochester General Hospital Rochester, NY
Ventilator Associated Pneumonia (VAP)
Ventilator Associated Pneumonia Best Practice Amy Shay, MS, CCRN, CNS Amy Shay, MS, CCRN, CNS.
Sean Berenholtz, MD MHS FCCM September 20, 2011 at 2ET/1 CT/12 MT/11 PT Ventilator Associated Pneumonia Prevention CLABSI Supplemental Call Series.
Ventilator-Associated Pneumonia Prevention Michael J. Apostolakos, MD Associate Professor of Medicine Director, Adult Critical Care University of Rochester.
Ventilator-Associated Pneumonia. Introduction Definition 48 hours after intubation mechanically ventilated No clinical evidence of pneumonia prior to.
The Importance of Clinical Oral Care
Journal Club. Background to the paper Pneumonia is THE MOST COMMON nosocomial infection in ICU patients 12 to 18 cases per 1000 ventilator days Oropharyngeal.
Ventilator Associated Pneumonia Overview
CAUTI Prevention.
© The Johns Hopkins University and The Johns Hopkins Health System Corporation, 2011 How Your Unit’s Policies and Protocols Compare to Other’s Kathleen.
American Association of Critical-Care Nurses: Practice Alert
Ventilator-Associated Pneumonia
Safer Healthcare Now! Ventilator Acquired Pneumonia Presented by Amanda Thompson, Safer Healthcare Now Facilitator April 12, 2007.
Preventing VAP - evidence for a care bundle. VAP Incidence ~ % ventilated patients 7-15 / 1000 ventilator days Atributable mortality of 0-50% Atributable.
TRACHEOSTOMY CARE AND EMERGENCIES. Indications for tracheostomy  Airway  Severe Facial Trauma,  Head and neck cancers / tumours  Acute Angioedema.
Reports: Daily Process, VAE, NHSN
CLABSI: Working Toward Zero Trinity Regional Health System Infection Prevention and Control Presented by: Patricia Herath, BSN, RNC Infection Preventionist.
University of Rochester Strong Health
Oral Care: State of the Science Vicki J. Spuhler RN MS Nurse Manager RICU LDS Hospital.
Oral Care for Patients at Risk for Ventilator-Associated Pneumonia Issued April 2010.
GENERAL TEMPLATE FOR A 48”X36” POSTER Name(s) of Author(s) 1 ; Name(s) of Author(s) 2 ; Name(s) of Author(s) 3 1. Name of Institution; 2. Name on Institution;
Clinical Uses and Ramifications of VAE Data
The Cardiac Surgery Translational Study (“CSTS”) The Quality And Safety Research Group Ventilator Associated Pneumonia Prevention Sean Berenholtz, MD MHS.
Care of the Client with an Artificial Airway
Part I BACKGROUND VENTILATOR ASSOCIATED PNEUMONIA.
CUSP for VAP: EVAP On Boarding Call #5: Evidence Review Sean Berenholtz M.D., MHS Nishi Rawat, M.D. September 18 th, :00 pm EST/ 11:00 am PST.
Pneumonia Dr. Abdul-Monim Batiha Assistant Professor Critical Care Nursing Philadelphia university.
© The Johns Hopkins University and The Johns Hopkins Health System Corporation, 2011 VAP Prevention Bundle: Evidence Review for Oral Care and Subglottic.
ความหมาย As Pneumonia in patient who have been on mechanical ventilation for greater than 48 hrs.
Lou Ann Bruno, MD Chief of Infectious Diseases and Medical Director Of Infection Prevention NHSN Benchmark Med-Surg ICU:
Linking Research, Audit, Quality Improvement and Evidence- Based Medicine Dr Chris Cairns 2010.
CUSP 4 MVP – VAP Cohort 2 Data Webinar 2 How to Complete the Exposure Receipt Assessment | Preliminary Structural Assessment Data Reports Wednesday, February.
The Comprehensive Unit Based Safety Program (CUSP)
Spontaneous Awakening and Breathing Trials Brad Winters MD, PhD March 14, 2013.
CUSP 4 MVP-VAP: Subglottic Suction ETT Implementation
Mini BAL v/s Bronchoscopic BAL PROF. PRADYUT WAGHRAY MD (CHEST), DTCD, FCCP (USA),D.SC(PULM. MEDICINE) HEAD OF DEPT. OF PULMONARY MEDICINE S.V.S MEDICAL.
CUSP 4 MVP – VAP Improving Care for Mechanically Ventilated Patients Data Feedback: SubG ETT, Head of Bed Elevation and Delirium Assessment Utilization.
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals 2014 Update Dr Neda Alijani.
Context, Interpretation, Next Steps Linda Greene MS, RN Michael Klompas MD, MPH November 12, 2014 CUSP for Mechanically Ventilated Patients Interim Results.
© The Johns Hopkins University and The Johns Hopkins Health System Corporation, 2011 Providing Feedback: Structural Assessment 2 Results & Exposure Receipt.
© The Johns Hopkins University and The Johns Hopkins Health System Corporation, 2011 CSTS -VAP Prevention Data Collection Instructions Presented by Sean.
PREVENTION Kaplan University Capstone NU499 VENTILATOR – ASSOCIATED PNEUMONIA VAP PREVENTION at Sparks Regional Medical Center.
Ventilator-Associated Pneumonia (VAP) An Overview for RC Students Special thanks to: Donald Dumford Donald Dumford Beth Israel Deaconess Medical Center.
Ventilator Associated Pneumonia. Ventilator-associated pneumonia (VAP) is a form of hospital-associated pneumonia (HAP) which develops in mechanically.
Is a Strategy Based on Routine Endotracheal Cultures the Best Way to Prescribe Antibiotics in Ventilator-Associated Pneumonia? CHEST 2013; 144(1):63-71.
Weaning From Mechanical Ventilation
Ventilator-Associated Pneumonia
Purpose To decrease the number of Ventilator-Associated Pneumonias (VAP) at the SMBD-JGH.
Monitoring Patients on Mechanical Ventilation: A New Paradigm Terri Conner, Ph.D. Nybeck Analytics May 2012.
Ventilator-associated pneumonia (VAP) prevention in Wales:
Subglottic Suctioning
A Quick Review: Preventing Ventilator-Associated Pneumonia (VAP)
Surveillance of Post-operative pneumonia
Rev: 17 January 2019.
Chapter 25 Respiratory Care Modalities
Ventilator-Associated Pneumonia
BIP Endotracheal Tube (ETT)
Presentation transcript:

VAP Intervention Information Armstrong Institute for Patient Safety and Quality

Objectives To review the definition and criteria for Ventilator Associated Pneumonia To review interventions included in the VAP Prevention Bundle To discuss the recording of the Process and Structural Measures

Armstrong Institute for Patient Safety and Quality Fast Facts 10-20% of ventilated patients Common HAI Median rate 1-4.3 per 1000 vent days 250,000 infections per year Most lethal HAI Mortality likely exceeds 10% Up to 36,000 deaths per year Cost per episode: $23,000 Armstrong Institute for Patient Safety and Quality

Armstrong Institute for Patient Safety and Quality Definition of VAP Pneumonia (PNEU) that occurs in patients who are intubated and ventilated at the time of or within 48 hours before the onset of pneumonia. Three Levels of PNEU – All Considered VAP PNEU 1-Clinically Defined PNEU 2- Pneumonia with Common Bacteriology PNEU 3-Pneumonia in Immunocompromised Patient Armstrong Institute for Patient Safety and Quality

Armstrong Institute for Patient Safety and Quality NHSN VAP Surveillance Flow Diagram Armstrong Institute for Patient Safety and Quality

Armstrong Institute for Patient Safety and Quality Interventions 5 Process Measures 14 Policy or Structural Measures Armstrong Institute for Patient Safety and Quality

Process measures: Daily evaluation Head of Bed Elevation (HOB) Use of a semi-recumbent position ( ≥ 30 degrees). Spontaneous Awakening and Breathing Trials (SAT & SBT) Make a daily assessment of readiness to wean with the use of the SAT and SBT. Oral Care At least 6 times per day Oral Care with Chlorhexidine. Should be included in the oral care regimen 2 times per day Subglottic Suctioning* Use subglottic suctioning ETTs in patients expected to be mechanically ventilated for >72 hours *Note - Not all sites will be using the subglottic suctioning ETTs for this project. If you are not, please use this information as education. Armstrong Institute for Patient Safety and Quality

Policy or Structural measures: Monthly evaluation in TCT Use a closed ETT* suctioning system Change close suctioning catheters only as needed Change ventilator circuits only if damaged or soiled Change HME** every 5-7 days and as clinically indicated Provide easy access to NIVV*** equipment and institute protocols to promote use Periodically remove condensate from circuits, keeping the circuit closed during the removal, taking precautions not to allow condensate to drain toward patient *ETT endotracheal tube; **HME heat moist exchanger; ***NIVV non-invasive ventilation Armstrong Institute for Patient Safety and Quality

Policy or Structural measures: Monthly evaluation in TCT Use early mobility protocol Perform hand hygiene Avoid supine position Use standard precautions while suctioning respiratory tract secretions Use orotracheal intubation instead of nasotracheal Avoid use of prophylactic systemic antimicrobials Avoid non-essential tracheal suctioning Avoid gastric over-distention Armstrong Institute for Patient Safety and Quality

Head of Bed Elevation

Head of Bed Elevation : VAP Prevention Guidelines Recommends head of bed elevation at an angle of 30–45 degrees for patients with a high risk for aspiration (e.g., a person receiving mechanically assisted ventilation) in the absence of medical contraindication. CDC; MMWR Recomm Rep. 2004;53:1-36 Recommends that patients should be kept in a semi-recumbent position (30-45 degrees) rather than supine to prevent aspiration. ATS/IDSA; AJRCCM 2005;171(4):388-416. Armstrong Institute for Patient Safety and Quality

Head of Bed Elevation : VAP Prevention Guidelines Recommends the head of bed elevation to be 45 degrees, as long as not contraindicated. Canadian VAP Prevention Guidelines; J Crit Care 2008;23(1):138-147. Recommends the use semi-recumbent position (30-45 degrees) as a strategy to prevent aspiration. SHEA; ICHE 2008;29:S31-S40. Armstrong Institute for Patient Safety and Quality

Spontaneous Awakening and Breathing Trials (SAT &SBT)

Spontaneous Awakening and Breathing Trials : VAP Prevention Guidelines Does not specifically address SAT and SBT, however supports weaning. CDC; MMWR Recomm Rep. 2004;53:1-36 Recommends use of daily interruption or lightening of sedation to avoid constant heavy sedation and to facilitate and accelerate weaning. Does not specifically address SBT. ATS/IDSA; AJRCCM 2005;171(4):388-416. Armstrong Institute for Patient Safety and Quality

Spontaneous Awakening and Breathing Trials : VAP Prevention Guidelines Guideline excluded studies that evaluated SAT and SBT. Canadian VAP Prevention Guidelines; J Crit Care 2008;23(1):138-147. Recommends the use of combining a daily assessment of readiness wean and daily sedation interruption. SHEA; ICHE 2008;29:S31-S40. Armstrong Institute for Patient Safety and Quality

Oral Care with Chlorhexidine

Use Chlorhexidine when performing oral care: VAP Prevention Guidelines No specific recommendation can be made for the routine use of an oral chlorhexidine rinse. (Unresolved issue) CDC; MMWR Recomm Rep. 2004;53:1-36 Recommends regular oral care. CHG effective in specific populations (ie: CABG); routine use is not recommended until more data is available. ATS/IDSA; AJRCCM 2005;171(4):388-416. Armstrong Institute for Patient Safety and Quality

Chlorhexidine when performing oral care: VAP Prevention Guidelines Oral antiseptic CHG should be considered. Based on 1 level 1 and 2 level 2 trials, use of oral antiseptic CHG may decrease VAP. Safety, feasibility, and cost considerations are all very favorable. Canadian VAP Prevention Guidelines; J Crit Care 2008;23(1):138-147. Perform regular oral care with an antiseptic solution. While the use of CHG is not specifically addressed, the 3 studies cited by the guideline all focused on cardiovascular surgery and demonstrated the efficacy of CHG. SHEA; ICHE 2008;29:S31-S40. Armstrong Institute for Patient Safety and Quality

CHG Oral Care: Evidence Gingival and dental plaque rapidly becomes colonized with bacteria in intubated patients due to poor oral hygiene and lack of mechanical elimination Meticulous oral care reduces microbial burden in upper airway Safety and feasibility of CHG oral care are favorable DeRiso A. Chest. 1996;109:1556. Chan E. BMJ. 2007;10:1136. Chlebicki M Crit Care Med 2007;35:595.

Oral Antiseptics: 2011 Systematic Review and Meta-Analysis 12 RCTs evaluating CHG (2341 patients) Overall 38% VAP reduction RR 0.72, 95%CI 0.55-0.94 Results varied by CHG concentration 2% > 0.2% > 0.12% Cardiac Surgery ICUs 59% VAP reduction RR 0.41, 95% CI 0.17-0.98 Labeau Lancet Infect Dis 2011;11:845-54 Armstrong Institute for Patient Safety and Quality

Oral Antiseptics: A Systematic Review and Meta-Analysis Labeau Lancet Infect Dis 2011;11:845-54 Armstrong Institute for Patient Safety and Quality

Oral Antiseptics: A Systematic Review and Meta-Analysis Variation by ICU Type Cardiac Surgery only (n=2, 914 patients) RR 0.41, 95% CI 0.17-0.98 Mixed ICUs (n=10, 1294 patients) RR 0.77, 95% CI 0.58-1.02 Surgery or Trauma (n=2, 273 patients) RR 0.67, 95% CI 0.50-0.88 Labeau Lancet Infect Dis 2011;11:845-54 Armstrong Institute for Patient Safety and Quality

CHG Oral Care: Recommendations Chlorhexidine 0.12% oral solution (15 ml bid until 24 hours after extubation) for all intubated patients Contraindications Hypersensitivity to component of solution <2 months of age There is the possibility of direct contact with meninges Brush patients’ teeth bid with soft toothbrush to remove dental plaque prior to using CHG Oral Care should be performed q4; Oral Care with CHG should be performed q12.

Subglottic suctioning ETTs in patients mechanically ventilated for >72 hours* *Note - Not all sites will be using the subglottic suctioning ETTs for this project. If you are not, please use this information as education.

Subglottic suctioning ETTs: VAP Prevention Guidelines Recommend ETTs with a dorsal lumen above the cuff to allow drainage (by continuous or frequent intermittent suctioning) of tracheal secretions. CDC; MMWR Recomm Rep. 2004;53:1-36 Recommend specially designed endotracheal tube (dorsal lumen) for continuous aspiration of subglottic secretions ATS/IDSA; AJRCCM 2005;171(4):388-416. Armstrong Institute for Patient Safety and Quality

Subglottic suctioning ETTs: VAP Prevention Guidelines Recommended subglottic secretion drainage in patients expected to be mechanically ventilated for more than 72 hours. Canadian VAP Prevention Guidelines; J Crit Care 2008;23(1):138-147. Recommend the use of cuffed ETT with in line or subglottic suctioning. SHEA; ICHE 2008;29:S31-S40. Armstrong Institute for Patient Safety and Quality

Subglottic suctioning ETTs: Evidence Drainage of subglottic secretions lessens the risk of aspiration Specially designed endotracheal tubes have been developed to provide continuous or intermittent subglottic secretion removal Kollef M. Chest. 1999;116:1339. Smulders K. Chest 2002;121:858.

Subglottic Suctioning ETTs Valles J, et al. Ann Intern Med. 1995;122:179.

Subglottic Suctioning ETTs: Evidence 13 RCTs evaluating subglottic secretion drainage (2442 patients) Overall 45% VAP reduction RR 0.55 (95% CI 0.46–0.66) NNT = 11 1.5 day ICU LOS reduction 1.1 day duration of MV reduction Muscedere J. Crit Care Med. 2011;39:1985.

Subglottic Suctioning ETTs: A Systematic Review and Meta-Analysis Muscedere J. Crit Care Med. 2011;39:1985. Armstrong Institute for Patient Safety and Quality

Subglottic Suctioning ETTs: A Systematic Review and Meta-Analysis Similar results if limited to studies of high methodologic quality Two studies evaluated only cardiac surgery patients (n=1057) Muscedere J. Crit Care Med. 2011;39:1985. Armstrong Institute for Patient Safety and Quality

Subglottic Suctioning ETTs: A Cost Effectiveness Analysis Conclusion: Regular utilization of CSS-ETs may produce significant cost savings, irrespective of the increased costs of CSS-ETs. Muscedere J. Crit Care Med. 2011;39:1985. Armstrong Institute for Patient Safety and Quality

Subglottic Suctioning ETTs: Recommendations Continuous subglottic suctioning system recommended for patients expected to be mechanically ventilated for >72 hours Unanswered questions How to identify pts that will require MV > 3 days; most studies used SDD ETTs for all patients undergoing major surgery Should ETTs be changed if patients require MV > 3 days.

How to Measure your VAP Rate Armstrong Institute for Patient Safety and Quality

Armstrong Institute for Patient Safety and Quality VAP Rates # VAP Cases _______________ x 1000 # ventilator days Armstrong Institute for Patient Safety and Quality